Exelixis | EXEL - Azione





Azione Cambiamento Data
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Akebia Therapeutics USD 13M 2.61M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.93B 362M 2026-06
Bayer EUR 12.01B 321M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Eisai JPY 257.55B 21.09B 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Exelixis USD 26.6M 4.92M 2026-03
Genmab DKK 13M 1000K 2025-06
Glaxosmithkline GBP 6.16B 39M 2026-03
Incyte USD 112.54M 3.08M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 280M 134M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Sanofi EUR 23.5B 812M 2026-03
Takeda JPY 1.45T 50.64B 2026-06
Ultragenyx Pharmaceutical USD 55M 3M 2026-03